Emmaus Life Sciences Receives Notice of FDA PDUFA Date for Investigational L-glutamine Treatment for Sickle Cell Disease Nov 29, 2016 8:00am EST
Emmaus' New Drug Application for Sickle Cell Disease Accepted for Review by FDA Nov 08, 2016 8:00am EST
Emmaus Life Sciences Completes $20 Million Private Placement From Two Korean-based Public Companies Oct 03, 2016 8:00am EDT
Emmaus Life Sciences Submits New Drug Application for Sickle Cell Disease Treatment Sep 08, 2016 8:00am EDT
Emmaus Life Sciences to Seek Marketing Approval for First New Sickle Cell Disease Treatment in Nearly 20 Years; Expects to Submit New Drug Application to FDA in September Aug 22, 2016 8:00am EDT
Emmaus Life Sciences Secures Funding to Advance Sickle Cell Disease Treatment Jan 26, 2016 8:00am EST
